As of August 2024, Celltrion Pharm has a market cap of $2.24B. This makes Celltrion Pharm the world's 4863th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $3.21B | 11.50% |
2023 | $2.88B | 44.71% |
2022 | $1.99B | -43.53% |
2021 | $3.53B | -46.30% |
2020 | $6.57B | 511.49% |
2019 | $1.07B | -34.19% |
2018 | $1.63B | 3.76% |
2017 | $1.57B | 161.19% |
2016 | $602.34M | 42.59% |
2015 | $422.44M | 98.12% |
2014 | $213.23M | -7.62% |
2013 | $230.81M | -49.70% |
2012 | $458.87M | - |